One fifth of Europe's biopharma firms "at risk of bankruptcy"
16 March 2009
Ian Schofield
Please Login to read the full article.
16 March 2009
Ian Schofield
The European biotechnology industry is calling for urgent action at both EU and national levels after a new study suggested that a fifth of small European biopharmaceutical companies could be facing bankruptcy by the end of the year as a result of the global financial crisis.
The...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- US Capitol Capsule: Will pharma get fried in the debt ceiling chicken game?
- Obama proposes tax incentives aimed at returning manufacturing to US
- US Capitol Capsule: Will PDUFA V be a 'damned if it does, damned if it doesn't' scenario for FDA?
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
